Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Am J Pathol. 2013 May;182(5):1519-31. doi: 10.1016/j.ajpath.2013.01.050. Epub 2013 Mar 15.
Epithelial host defense proteins comprise a critical component of the pulmonary innate immune response to infection. The short palate, lung, nasal epithelium clone (PLUNC) 1 (SPLUNC1) protein is a member of the bactericidal/permeability-increasing (BPI) fold-containing (BPIF) protein family, sharing structural similarities with BPI-like proteins. SPLUNC1 is a 25 kDa secretory protein that is expressed in nasal, oropharyngeal, and lung epithelia, and has been implicated in airway host defense against Pseudomonas aeruginosa and other organisms. SPLUNC1 is reported to have surfactant properties, which may contribute to anti-biofilm defenses. The objective of this study was to assess the importance of SPLUNC1 surfactant activity in airway epithelial secretions and to explore its biological relevance in the context of a bacterial infection model. Using cultured airway epithelia, we confirmed that SPLUNC1 is critically important for maintenance of low surface tension in airway fluids. Furthermore, we demonstrated that recombinant SPLUNC1 (rSPLUNC1) significantly inhibited Klebsiella pneumoniae biofilm formation on airway epithelia. We subsequently found that Splunc1(-/-) mice were significantly more susceptible to infection with K. pneumoniae, confirming the likely in vivo relevance of this anti-biofilm effect. Our data indicate that SPLUNC1 is a crucial component of mucosal innate immune defense against pulmonary infection by a relevant airway pathogen, and provide further support for the novel hypothesis that SPLUNC1 protein prevents bacterial biofilm formation through its ability to modulate surface tension of airway fluids.
上皮宿主防御蛋白是肺部固有免疫反应对感染的重要组成部分。短腭、肺、鼻上皮克隆(PLUNC)1(SPLUNC1)蛋白是杀菌/通透性增加(BPI)折叠含(BPIF)蛋白家族的成员,与 BPI 样蛋白具有结构相似性。SPLUNC1 是一种 25 kDa 的分泌蛋白,在鼻、口咽和肺上皮中表达,被认为参与气道防御假单胞菌和其他生物体。据报道,SPLUNC1 具有表面活性剂特性,这可能有助于抗生物膜防御。本研究的目的是评估 SPLUNC1 表面活性剂活性在气道上皮分泌物中的重要性,并探索其在细菌感染模型中的生物学相关性。通过培养气道上皮细胞,我们证实 SPLUNC1 对维持气道液体内的低表面张力至关重要。此外,我们证明重组 SPLUNC1(rSPLUNC1)显著抑制了肺炎克雷伯菌在气道上皮上的生物膜形成。随后,我们发现 Splunc1(-/-)小鼠对肺炎克雷伯菌感染的敏感性显著增加,证实了这种抗生物膜作用的体内相关性。我们的数据表明,SPLUNC1 是一种重要的黏膜固有免疫防御成分,可抵抗相关气道病原体引起的肺部感染,并进一步支持 SPLUNC1 蛋白通过调节气道液体内的表面张力来防止细菌生物膜形成的新假说。